# Vistagen (VTGN) — News

VTGN · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vtgn/news

## Recent headlines

- [Vistagen Therapeutics, - Preparing to meet with FDA this quarter for proposed new phase 3 trial](https://www.ainvest.com/news/vistagen-therapeutics-preparing-meet-fda-quarter-proposed-phase-3-trial-2609) — AInvest Wire, Sep 22, 2026
  Vistagen Therapeutics is preparing to engage in discussions with the U.S. Food and Drug Administration (FDA) in the current quarter regarding a proposed new phase 3 clinical trial [1]. The company has indicated that the meeting will focus on the design and regulatory requirements for the trial,…
- [Vistagen Therapeutics: Discontinuation rate due to adverse events was 1.6%, none attributed to Fasedienol](https://www.ainvest.com/news/vistagen-therapeutics-discontinuation-rate-due-adverse-events-1-6-attributed-fasedienol-2609) — AInvest Wire, Sep 22, 2026
- [Vistagen Therapeutics: No serious adverse events related to Fasedienol reported](https://www.ainvest.com/news/vistagen-therapeutics-adverse-events-related-fasedienol-reported-2609) — AInvest Wire, Sep 22, 2026
- [Vistagen Therapeutics: Fasedienol nasal spray well-tolerated with no new drug-related safety findings after 12 months](https://www.ainvest.com/news/vistagen-therapeutics-fasedienol-nasal-spray-tolerated-drug-related-safety-findings-12-months-2609) — AInvest Wire, Sep 22, 2026
- [Vistagen announces preliminary positive data from open-label extension portion of Palisade-4 phase 3 study of Fasedienol for the acute treatment of social anxiety disorder](https://www.ainvest.com/news/vistagen-announces-preliminary-positive-data-open-label-extension-portion-palisade-4-phase-3-study-fasedienol-acute-treatment-social-anxiety-disorder-2609) — AInvest Wire, Sep 22, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).